We at ACW Canterlilly recognize the medical needs have no boarder and improvements in care come from exposure to global health trends. Our team-based experience of pharmaceuticals, systems engineering, health care accounting, and expertise in International Health Policy and Oncology has positioned us as a leading consulting group.

Our primary site of excellence are the processes and boundary pushing innovation of the United States medical system. Furthermore, we have consultation experience within the European Union with oncology focused workflow improvement and pharmacy solutions tailored to individual member regulation within the EU Pharmacopeia. Our experience with multi-national job providers has enabled us to effectively and constructively consult with them regard best options for insurance care when entering into the US market for their employees and family members.

Close affiliation with the National Health Service in the United Kingdom and the health needs of other commonwealth countries such as Canada and Australia, has provided a deep pool of Knowledge Leaders to draw up and assist in improvement initiatives. We are especially proud of assisting on rollout of Oncology eMAR technologies in the Health and Social Care Trusts of Northern Ireland's Department of Health (An Roinn Sláinte).

In addition, we pay close attention to protocols and advancements within the space of Japanese Health Care. Due to the close relationship of Japanese Pharmaceutical companies and current innovative Oncology products, keen knowledge of the pharmacopeia and best oncology practices results in greater understanding and expertise in groundbreaking areas such as Colo-Rectal Cancer.